Sign In
Buy EW
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026
Edwards Lifesciences Corporation (EW) Presents at TD Cowen 46th Annual Health Care Conference Transcript
12:07pm, Monday, 02'nd Mar 2026
Edwards Lifesciences Corporation (EW) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Edwards Lifesciences Corporation (EW) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript
01:28pm, Thursday, 26'th Feb 2026
Edwards Lifesciences Corporation (EW) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript
Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose
09:15am, Thursday, 26'th Feb 2026
IRVINE, Calif.--(BUSINESS WIRE)--At the close of Heart Month, Edwards Lifesciences (NYSE: EW) underscored its leadership in structural heart innovation, advancing care through deep expertise and stron
3 Medical Instrument Stocks Banking on GenAI to Tackle Industry Woes
09:56am, Monday, 23'rd Feb 2026
ISRG, EW and ELMD tap GenAI to enhance diagnostics and workflows, even as MedTech faces cost pressures, data risks and macro headwinds.
Lansforsakringar Fondforvaltning AB publ Increases Position in Edwards Lifesciences Corporation $EW
06:05am, Monday, 23'rd Feb 2026
Lansforsakringar Fondforvaltning AB publ boosted its holdings in shares of Edwards Lifesciences Corporation (NYSE: EW) by 4.1% during the undefined quarter, according to the company in its most recent
Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences
07:05am, Thursday, 19'th Feb 2026
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced its chief financial officer, Scott Ullem, is scheduled to present at two upcoming conferences: Tuesday, Mar
Edwards Lifesciences scraps anti-copycat policy, EU drops antitrust investigation
05:49am, Monday, 16'th Feb 2026
U.S. medical device maker Edwards Lifesciences has scrapped its anti-copycat policy that triggered a complaint from an Indian rival, EU antitrust regulators said on Monday as they closed their investi
Edwards Lifesciences to Present at Citi's 2026 Unplugged Medtech and Life Sciences Access Day
07:05am, Friday, 13'th Feb 2026
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in Citi's Unplugged Medtech and Life Sciences Access Day on February 26, 2026. Scott Ul
Edwards Lifesciences Corporation (NYSE:EW) Given Average Rating of “Moderate Buy” by Analysts
01:52am, Friday, 13'th Feb 2026
Edwards Lifesciences Corporation (NYSE: EW - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the twenty-seven analysts that are covering the company, MarketBeat Ratings
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH
01:27pm, Thursday, 12'th Feb 2026
More than just a financial check-up, earnings for companies in the healthcare sector offer a key window for investors into a firm's pipeline and development progress. Even well-established, stable fir
Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights
12:26pm, Thursday, 12'th Feb 2026
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. Shareholders should contact the firm immediately as there may be limited time to enforce your righ
Options Corner: Edwards Lifesciences Poor Start To The New Year Offers A Contrarian Opportunity
05:02pm, Wednesday, 11'th Feb 2026
With Edwards Lifesciences getting a key earnings report out of the way, the uncertainties hanging over EW stock has cleared for the bulls.
EW's Q4 Earnings Miss Estimates, Revenues Up Y/Y, Stock Climbs
09:20am, Wednesday, 11'th Feb 2026
Edwards' Q4 EPS lags estimates but revenues top as TAVR and TMTT surge. Shares rise with 2026 sales growth seen at 8%-10%.
Edwards Lifesciences Corp (EW) Q4 2025 Earnings Call Highlights: Strong Sales Growth Amidst Strategic Investments
12:01am, Wednesday, 11'th Feb 2026
Total Sales: $1.57 billion, grew 11.6% year over year.Adjusted EPS: $0.58, lower due to higher spending and tax rate.GAAP EPS: $0.11, impacted by one-time char
Edwards Lifesciences Corporation (EW) Q4 2025 Earnings Call Transcript
07:54pm, Tuesday, 10'th Feb 2026
Edwards Lifesciences Corporation (EW) Q4 2025 Earnings Call Transcript
